Zdrowie i gospodarka · 21/05/2008

FDA Releases Draft Guidance for Blood Donors Deferred Due to False Positive Hepatitis B Test Results

The FDA has made available a draft document outlining a requalification method for blood donors who were previously deferred due to reactive test results for the antibody to Hepatitis B core antigen (Anti-HBc), allowing them to reenter the donor pool if the initial test results were false positives.